For instance, research indicates that patients with IBD exhibit increased activation and proliferation of both CD4+ and CD8+ T cells in the intestinal mucosa, leading to an imbalance in the CD4:CD8 ratio. The gene discussed is CD8A; the disease is inflammatory bowel disease.